Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic 2019
2019 Utilization of an alternative docetaxel-based intraperitoneal chemotherapy regimen in patients with ovarian, fallopian tube or primary peritoneal carcinoma 2019
2018 Enhanced Recovery After Surgery in Surgical Specialties: Gynecologic Oncology 2018
2018 Impact of enhanced recovery after surgery (ERAS) protocol on gastrointestinal function in gynecologic oncology patients undergoing laparotomy 2018
2018 The impact of racial, geographic, and socioeconomic risk factors on the development of advanced-stage cervical cancer 2018
2018 Predictors of Unplanned Reoperation for Ovarian Cancer Patients from the National Surgical Quality Improvement Program Database 2018
2018 Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years 2018
2018 High Rates of High-Grade Cervical Dysplasia in High-Risk Young Women with Low-Grade Cervical Cytology 2018
2018 Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic 2018
2018 Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma 2018
2018 Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer? 2018
2018 Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma 2018
2018 Feasibility of complete salpingectomy compared with standard postpartum tubal ligation at cesarean delivery a randomized controlled trial 2018
2017 Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study 2017
2017 The evolution of and evidence for opportunistic salpingectomy 2017
2017 Malignant Brenner tumor associated with a germline BRCA2 mutation 2017
2017 A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study 2017
2017 Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma – A multi-institutional cohort 2017
2017 Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174? 2017
2017 Does obesity affect pathologic agreement of initial and final tumor grade of disease in endometrial cancer patients? 2017
2016 Drawing the Line in Risk-Reducing Gynecologic Surgery in Women with a BRCA Mutation 2016
2016 Improved outcomes with dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma 2016
2016 See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology? 2016
2016 Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes? 2016
2016 Staging Lymphadenectomy in Patients with Clear Cell Carcinoma of the Ovary 2016
2015 The Impact of Diabetes on Gynecologic Cancer: Current Status and Future Directions. 2015
2015 PARP inhibitor maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: A cost-effectiveness analysis 2015
2015 Does a standardized preoperative algorithm of clinical data improve outcomes in patients with ovarian cancer? A quality improvement project 2015
2015 Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: Is it cost-effective? 2015
2015 Evaluation of in vitro chemoresponse profiles in women with Type i and Type II epithelial ovarian cancers: An observational study ancillary analysis 2015
2015 Laparoscopic staging of ovarian immature teratomas: A report on three cases 2015
2014 A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer 2014
2014 Black race independently predicts worse survival in uterine carcinosarcoma 2014
2014 Combination therapy with paclitaxel, carboplatin and megestrol acetate for the management of advanced stage or recurrent carcinoma of the endometrium: a phase II study. 2014
2014 Cost-effectiveness analysis of sentinel lymph node biopsy in the treatment of early-stage vulvar cancer 2014
2014 Diabetes mellitus and ovarian cancer: More complex than just increasing risk 2014
2014 Primary invasive breast carcinoma arising in mammary-like glands of the vulva managed with excision and sentinel lymph node biopsy 2014
2014 Radical surgical cytoreduction in the treatment of ovarian carcinosarcoma 2014
2014 Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center 2014
2013 Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer. 2013
2013 Trends in hospital volume and patterns of referral for women with gynecologic cancers: adherence to treatment guidelines for ovarian cancer as a measure of quality care. 2013
2013 Are supportive care-based treatment strategies preferable to standard chemotherapy in recurrent cervical cancer? 2013
2013 Growing teratoma syndrome: Brief communication and algorithm for management. 2013
2013 Chemotherapy for advanced and recurrent cervical carcinoma: Results from cooperative group trials 2013
2013 Comparison of operative risks associated with radical hysterectomy in pregnant and nonpregnant women 2013
2013 Malignant pericardial effusion and pericardial tumor involvement secondary to cervical cancer. 2013
2013 Surgical outcomes and national comprehensive cancer network compliance in advanced ovarian cancer surgery in a low volume military treatment facility 2013
2012 Re: "The utilization of palliative care in gynecologic oncology patients near the end of life". 2012
2012 Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix. 2012
2012 Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy 2012
2012 Robotic surgery applications in the management of gynecologic malignancies. 2012
2012 Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer. 2012
2012 Peripartum cardiomyopathy and acute fatty liver of pregnancy: One patient with two Zebras 2012
2011 Evaluation of the Patient-Generated Subjective Global Assessment (PG-SGA) as a predictor of febrile neutropenia in gynecologic cancer patients receiving combination chemotherapy: a pilot study. 2011
2011 Surgically managed stage I endometrial cancer in a low-volume center: outcomes and complications in a military residency program. 2011
2011 Incidence of subsequent abnormal cytology in cervical cancer patients completing five-years of post treatment surveillance without evidence of recurrence. 2011
2011 Multiple synchronous primary ovarian malignancies in a patient with a MLH-1 mutation: Impact on potential fertility preservation. 2011
2011 Reaction to a surgical implant foreign body masquerading as recurrent uterine sarcoma 2011
2010 Hospice enrollment for terminally ill patients with gynecologic malignancies: impact on outcomes and interventions. 2010
2010 Epithelioid trophoblastic tumor masquerading as invasive squamous cell carcinoma of the cervix after an ectopic pregnancy. 2010
2010 Undifferentiated uterine sarcoma presenting as a pathologic humerus fracture 2010
2009 Weekly topotecan and daily thalidomide in patients with recurrent epithelial ovarian cancer: a report of 2 cases. 2009
2009 Hot and blue Lymphoscintigraphy might be useful in cervical cancer surgery. 2009
2009 Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: Implications for adjuvant therapy 2009
2009 Cervical signet-ring cell carcinoma presenting as a synchronous primary carcinoma with uterine adenocarcinoma. 2009
2008 Conservative Management of Postoperative Fever in Gynecologic Patients Undergoing Major Abdominal or Vaginal Operations 2008
2008 Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer 2008
2007 Serous fallopian tube carcinoma: A retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary 2007
2007 Outcomes for patients with fallopian tube carcinoma managed with adjuvant chemotherapy following primary surgery: A retrospective university experience 2007
2007 A multi-institutional review of outcomes of endometrial stromal sarcoma 2007
2007 Occult metastatic lung carcinoma presenting as locally advanced uterine carcinosarcoma on positron emission tomography/computed tomography imaging. 2007
2007 A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy 2007
2006 Surgical staging in endometrial cancer 2006
2006 Bowel Resection at the Time of Primary Debulking for Epithelial Ovarian Carcinoma: Outcomes in Patients Treated with Platinum and Taxane-Based Chemotherapy 2006
2006 Inflammatory pseudotumor of pelvic lymph nodes 2006
2006 Outcomes of gynecologic oncology patients admitted to the intensive care unit following surgery: A university teaching hospital experience. 2006
2006 Synchronous primary endometrial and ovarian carcinoma in a patient with marantic endocarditis. 2006
2006 Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer 2006
2006 Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patients 2006
2006 Current controversies in the biology and management of ovarian tumors of low malignant potential 2006
2006 Erratum: Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter (Gene Therapy (2004) vol. 11 (645-648) 10.1038/sj.gt.3302089) 2006
2006 Use of a fascial prosthesis for management of abdominal compartment syndrome secondary to obstetric hemorrhage. 2006
2005 Predictors of outcomes for women with cervical carcinoma 2005
2005 A cost-effectiveness analysis of screening strategies for cervical intraepithelial neoplasia 2005
2005 A prospective evaluation of "see and treat" in women with HSIL Pap smear results: Is this an appropriate strategy? 2005
2005 Management strategies for stage IB2 cervical cancer: A cost-effectiveness analysis 2005
2005 Occult choriocarcinoma discovered by positron emission tomography/computed tomography imaging following a successful pregnancy 2005
2005 Validation of referral guidelines for women with pelvic masses. 2005
2004 Protrusio acetabuli presenting as a complex pelvic mass after total hip arthroplasty 2004
2004 A cost-effectiveness analysis of screening strategies for cervical intraepithelial neoplasia 2004
2004 The impact of aborted radical hysterectomy in patients with cervical carcinoma 2004
2004 Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma 2004
2004 Feasibility study of liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked stage IIIC/IV ovarian cancer patients. 2004
2004 Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy 2004
2004 Transcriptional Blocks Limit Adenoviral Replication in Primary Ovarian Tumor 2004
2004 Transcriptional targeting of tumors with a novel tumor-specific survivin promoter 2004
2004 Immunohistochemical Evaluation of the c-kit Proto-oncogene in Sarcomas of the Uterus: A Case Series 2004
2004 Knowledge, Beliefs, and Practices Concerning Seat Belt Use during Pregnancy 2004
2004 Primary lung large cell carcinoma metastatic to the vulva: A case report and review of the literature 2004
2004 Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer 2004
2004 Single-chain antibodies: A therapeutic modality for cancer gene therapy (review). 2004
2004 The role of radical parametrectomy in the treatment of occult cervical carcinoma after extrafascial hysterectomy 2004
2004 Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter 2004
2003 Primary extrarenal rhabdoid tumor of the ovary: A case report 2003
2003 Complications of indwelling venous access devices in patients with gynecologic malignancies 2003
2003 Uterine papillary serous carcinoma: Comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy 2003
2002 A guest editorial: stump the professor. 2002
2002 Uterine leiomyosarcoma metastatic to the thyroid 2002
2002 Uterine leiomyosarcoma metastatic to the thyroid. 2002
2002 A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis 2002
2002 Conservative management of Stage I endometrial carcinoma after surgical staging 2002

Research Overview

  • Cervical cancer; ovarian cancer
  • Principal Investigator On

  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2018 - 2023
  • Private Grant  awarded by CELSION CORPORATION 2018 - 2023
  • Private Grant  awarded by ABBVIE INC 2018 - 2023
  • Private Grant  awarded by SYROS PHARMACEUTICALS INC. 2018 - 2023
  • Private Grant  awarded by GENMAB 2018 - 2023
  • Private Grant  awarded by TAPIMMUNE, INC. 2018 - 2023
  • Private Grant  awarded by Genentech 2017 - 2022
  • Private Grant  awarded by TESARO, INC. 2016 - 2021
  • Neoadjuvant Chemotherapy Tumor Profiling in Ovarian Cancer: Genomic and Proteomic Analysis  awarded by NRG ONCOLOGY FOUNDATION 2016 - 2021
  • Private Grant  awarded by MATEON THERAPEUTICS, INC. 2016 - 2021
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2016 - 2021
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility  awarded by National Cancer Institute/NIH/DHHS 2019 - 2021
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System  awarded by National Cancer Institute/NIH/DHHS 2019 - 2021
  • Private Grant  awarded by PLEXXIKON 2016 - 2021
  • Private Grant  awarded by ABBVIE INC 2015 - 2020
  • Private Grant  awarded by CELSION CORPORATION 2015 - 2020
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2015 - 2020
  • NRG Oncology Network Group Operations Center  awarded by NRG ONCOLOGY FOUNDATION 2019 - 2020
  • Comprehensive Cancer Center Core Support Grant - Cancer Clinical Investigator Team Leadership Award  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2018 - 2019
  • NRG Oncology Network Group Operations Center: Gynecologic Oncology Cancer Committee Chair  awarded by NRG ONCOLOGY FOUNDATION 2018 - 2019
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2018
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2017
  • Comprehensive Cancer Center Core Support Grant - Cancer Clinical Investigator Team Leadership Award (CCITLA)  awarded by National Cancer Institute/NIH/DHHS 2016 - 2017
  • Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility  awarded by National Cancer Institute/NIH/DHHS 2016 - 2017
  • Feasibility of the Institution of a Combination of Dedicated Nutritional Counseling and Exercise in Stage I Endometrial Cancer Patients following Minimally Invasive Surgery in the Post Operative Period  awarded by FOUNDATION FOR GYNECOLOGIC ONCOLOGY 2013 - 2016
  • Cancer Clinical Investigator Team Leadership Award  awarded by National Cancer Institute/NIH/DHHS 2011 - 2016
  • Private Grant  awarded by ASTRAZENECA AB 2014 - 2015
  • SPORE in Cervical Cancer - Cervical SPORE Pilot Project (Charles Leath)  awarded by Johns Hopkins University 2009 - 2014
  • Investigator On

  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2019 - 2025
  • Private Grant  awarded by PUMA BIOTECHNOLOGY, INC. 2019 - 2024
  • Private Grant  awarded by TESARO, INC. 2019 - 2024
  • Private Grant  awarded by IMMUNOGEN, INC. 2019 - 2024
  • Private Grant  awarded by EMD SERONO 2019 - 2024
  • Private Grant  awarded by DECIPHERA PHARMACEUTICALS. LLC 2018 - 2023
  • Private Grant  awarded by MILLENNIUM PHARMACEUTICALS, INC. 2018 - 2023
  • UAB 1753 A Randomized Placebo Controlled Phase II Trial of Metformin in Conjunction with Chemotherapy Followed by Metformin Maintenance Therapy in Advanced Stage Ovarian, Fallopian Tube and Primary Peritoneal Cancer  awarded by University of Chicago 2018 - 2023
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2023
  • Private Grant  awarded by SYNDAX PHARMACEUTICALS 2017 - 2022
  • Private Grant  awarded by Leap Therapeutics, Inc. 2017 - 2022
  • Private Grant  awarded by IMMUNOGEN, INC. 2017 - 2022
  • Private Grant  awarded by INCYTE CORPORATION 2017 - 2022
  • Private Grant  awarded by MedImmune 2019 - 2022
  • Overcoming PAAP Inhibitor Resistance of BACA-Deficient Ovarian Cancers  awarded by DOD - Department of Defense 2018 - 2021
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2019 - 2021
  • Improving Surgical Outcomes and Experience with Patient-Centered Technology  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION 2018 - 2020
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2014 - 2020
  • UAB 1764:The Targeted Agent and Profiling Utilization Registry (TAPUR) Study  awarded by American Society of Clinical Oncology 2017 - 2019
  • UAB 1788: Pilot Study of Daily Exemestane in Women with Complex Alypical Hyperplasia of The Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer (Fixed Price)  awarded by University of Wisconsin-Madison 2017 - 2019
  • UAB 1788; Pilot Study of Daily Exemestane in Women with Complex Alypical Hyperplasia of The Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer (Cost Reimbursable)  awarded by University of Wisconsin-Madison 2017 - 2019
  • SPORE in Cervical Cancer  awarded by Johns Hopkins University 2014 - 2019
  • SPORE in Cervical Cancer - Project 2  awarded by Johns Hopkins University 2014 - 2019
  • Private Grant  awarded by INCYTE CORPORATION 2018 - 2019
  • UAB NRG Oncology Master Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2019
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2015 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2014 - 2019
  • Private Grant  awarded by LICOR, INC. 2017 - 2019
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2014 - 2018
  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2016 - 2018
  • Using the Genomic Profile of High Intermediate Risk Endometrial Cancer Patients to Differentiate Patients at High Risk of Recurrence from the Majority with Low Risk of Recurrence  awarded by FOUNDATION FOR GYNECOLOGIC ONCOLOGY 2016 - 2017
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2016 - 2017
  • Private Grant  awarded by AMGEN, INC. 2012 - 2016
  • Ovarian Cancer Patient-Centered Decision Aid  awarded by University of California, Irvine 2014 - 2016
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2016
  • Gynecologic Oncology Group Clinical Trials  awarded by GYNECOLOGIC ONCOLOGY GROUP 2012 - 2016
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2011 - 2016
  • NCTN Deep South Research Consortium  awarded by National Cancer Institute/NIH/DHHS 2014 - 2016
  • Prospective Correlation of Multinational Association of Supportive Care of Cancer Risk-Index Score with Management of Gynecologic Oncology Patients with Neutropenic Fever  awarded by University of Oklahoma 2013 - 2015
  • OB/GYN Faculty Research Career Development Program  awarded by National Institute of Child Health and Human Development/NIH/DHHS 2010 - 2015
  • SPORE in Cervical Cancer  awarded by Johns Hopkins University 2009 - 2014
  • Teaching Activities

  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2019) 2019
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2019) 2019
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2019) 2019
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2019) 2019
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2019) 2019
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2019) 2019
  • STP10455 - ADVANCED GYNECOLOGIC ONCOLOGY (Spring Term 2019) 2019
  • STP2083 - INTENSIVE GYNECOLOGIC ONCOLOGY (Spring Term 2019) 2019
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2019) 2019
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2018) 2018
  • STP2083 - INTENSIVE GYNECOLOGIC ONCOLOGY (Fall Term 2018) 2018
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2018) 2018
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2018) 2018
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2018) 2018
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2018) 2018
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2018) 2018
  • STP2083 - INTENSIVE GYNECOLOGIC ONCOLOGY (Spring Term 2018) 2018
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2018) 2018
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2018) 2018
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2018) 2018
  • STP2083 - INTENSIVE GYNECOLOGIC ONCOLOGY (Fall Term 2017) 2017
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2017) 2017
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2017) 2017
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2017) 2017
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2017) 2017
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2017) 2017
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2017) 2017
  • STP2083 - INTENSIVE GYNECOLOGIC ONCOLOGY (Spring Term 2017) 2017
  • STP2083 - INTENSIVE GYNECOLOGIC ONCOLOGY (Fall Term 2016) 2016
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2016) 2016
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2016) 2016
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2016) 2016
  • 40-405 - GYNECOLOGIC ONCOLOGY (Fall Term 2016) 2016
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2016) 2016
  • 40-405 - GYNECOLOGIC ONCOLOGY (Spring Term 2016) 2016
  • STP2083 - INTENSIVE GYNECOLOGIC ONCOLOGY (Spring Term 2016) 2016
  • Education And Training

  • UAB Hospital, Residency 2002
  • UAB Hospital, Postdoctoral Fellowship 2005
  • Full Name

  • Charles Leath